Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Celcuity Inc. - Common Stock
(NQ:
CELC
)
100.00
+0.27 (+0.27%)
Streaming Delayed Price
Updated: 9:43 AM EST, Jan 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Celcuity Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
3 Stocks You’ll Wish You Bought Before 2026
↗
December 03, 2025
Via
MarketBeat
Celcuity Stock Near All-Time Highs — And This Major Biotech Investor Is Still Jumping In
↗
December 02, 2025
Via
The Motley Fool
This Fund Bought $38 Million of Celcuity as Stock Surges on Investigational Cancer Drug Results
↗
November 28, 2025
One clinical-stage biotech is defying gravity—here’s why its record-breaking run is catching institutional attention.
Via
The Motley Fool
Topics
Regulatory Compliance
This Fund Bought $38 Million of Celcuity as Stock Surges on Investigational Cancer Drug Results
↗
November 27, 2025
One clinical-stage biotech is defying gravity—here’s why its record-breaking run is catching institutional attention.
Via
The Motley Fool
Topics
Regulatory Compliance
Earnings Scheduled For November 12, 2025
↗
November 12, 2025
Via
Benzinga
Exploring Celcuity's Earnings Expectations
↗
November 11, 2025
Via
Benzinga
Earnings Scheduled For August 14, 2025
↗
August 14, 2025
Via
Benzinga
Insights into Celcuity's Upcoming Earnings
↗
August 13, 2025
Via
Benzinga
GEO Shares Down 44% as Fund Sells $9 Million in Stock Amid ICE Allegations and Softer Outlook
↗
November 27, 2025
GEO’s latest quarter shows a company pulling in record contracts while wrestling with litigation and cooling earnings guidance—here’s what investors need to know.
Via
The Motley Fool
Topics
Immigration
Regulatory Compliance
Celcuity Analyst No Longer Bullish Despite Breast Cancer Therapy Application
↗
November 17, 2025
FDA accepts NDA for Celcuity's advanced breast cancer therapy. Analyst downgrades stock due to high valuation. Next catalyst is topline data.
Via
Benzinga
CELCUITY INC (NASDAQ:CELC) Stock Surges 70% in a Month Following Q3 Earnings Beat and Positive Clinical Data
↗
November 12, 2025
Celcuity stock surges after a Q3 earnings beat and positive clinical data for its lead drug candidate, gedatolisib.
Via
Chartmill
Topics
Earnings
Celcuity Eyeing Cancer Treatment Riddle. Stock Flys 534% This Year.
↗
November 05, 2025
The company hopes to "solve a 20-year riddle" in cancer treatment. The journey has sent the biotech stock flying as much as 534%.
Via
Investor's Business Daily
These stocks are moving in today's session
↗
October 20, 2025
Let's have a look at what is happening on the US markets one hour before the close of the markets on Monday. Below you can find the top gainers and losers in today's session.
Via
Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
↗
October 20, 2025
Via
Benzinga
Top movers analysis in the middle of the day on 2025-10-20: top gainers and losers in today's session.
↗
October 20, 2025
Curious to know what's happening on the US markets in the middle of the day on Monday? Join us as we explore the top gainers and losers in today's session.
Via
Chartmill
Gapping stocks in Monday's session
↗
October 20, 2025
Today's session on Monday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.
Via
Chartmill
WW International, Replimune Group, Datavault AI, GRAIL And Other Big Stocks Moving Higher On Monday
↗
October 20, 2025
Via
Benzinga
Topics
Artificial Intelligence
Top 1% Celcuity Shoots To Record High On Roche-Rivaling Breast Cancer Results
↗
October 20, 2025
The company said its breast cancer treatment delayed progression for a median of 19.7 months in some patients.
Via
Investor's Business Daily
Topics
Government
Dow Jumps Over 200 Points; Cleveland-Cliffs Shares Jump After Q3 Results
↗
October 20, 2025
Via
Benzinga
Topics
Stocks
These stocks are moving in today's pre-market session
↗
October 20, 2025
As we await the opening of the US market on Monday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.
Via
Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
October 20, 2025
Via
Benzinga
Why Delcath Systems Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket
↗
October 20, 2025
Via
Benzinga
Clinical Breakthroughs Converge as Immunotherapy Market Surges Past $136 Billion
October 06, 2025
EQNX::TICKER_START (NASDAQ:GTBP),(NASDAQ:LPTX),(NASDAQ:IOBT),(NASDAQ:CELC),(NYSE:MAIA) EQNX::TICKER_END
Via
FinancialNewsMedia
Celcuity Q2 Results Highlight Cash Surge
↗
August 14, 2025
Via
The Motley Fool
Celcuity (CELC) Q2 2025 Earnings Call Transcript
↗
August 14, 2025
Via
The Motley Fool
Topics
Earnings
Celcuity Expenses Jump 81 Percent
↗
August 14, 2025
Via
The Motley Fool
CELCUITY INC (NASDAQ:CELC) Reports Q2 2025 Earnings Miss Amid Clinical Progress in Gedatolisib Trials
↗
August 14, 2025
Celcuity (CELC) reported Q2 2025 results with a wider-than-expected EPS loss but revenue in line. Clinical progress in breast cancer trials drives investor optimism despite financial misses.
Via
Chartmill
Topics
Earnings
Unusual volume stocks are being observed in Wednesday's session.
↗
July 30, 2025
The trading volume of these stocks is deviating from the norm in today's session.
Via
Chartmill
The trading volume of these stocks is deviating from the norm in today's session.
↗
July 29, 2025
Discover the stocks with unexpected trading volume in today's session on the US markets.
Via
Chartmill
Peraso (NASDAQ: PRSO) Powers Military, Nex-Gen Broadband Surge – Mag 7 Undercard VAPE CELC, CRVO – More Stocks Inside
July 28, 2025
Via
AB Newswire
Topics
Supply Chain
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
